We are live on ! Find out more
BSX icon

Boston Scientific

1,150 hedge funds and large institutions have $77.3B invested in Boston Scientific in 2023 Q4 according to their latest regulatory filings, with 101 funds opening new positions, 443 increasing their positions, 378 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more first-time investments, than exits

New positions opened: 101 | Existing positions closed: 69

17% more repeat investments, than reductions

Existing positions increased: 443 | Existing positions reduced: 378

9% more funds holding

Funds holding: 1,056 → 1,150 (+94)

0.11% less ownership

Funds ownership: 91.37% → 91.26% (-0.11%)

5% less call options, than puts

Call options by funds: $513M | Put options by funds: $538M

7% less funds holding in top 10

Funds holding in top 10: 29 → 27 (-2)

13% less capital inflows, than outflows

Capital inflows: $3.49B | Capital outflows: $3.99B

Holders
1,150
Holders Change
+94
Holders Change %
+8.9%
% of All Funds
16.72%
Holding in Top 10
27
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-6.9%
% of All Funds
0.39%
New
101
Increased
443
Reduced
378
Closed
69
Calls
$513​M
Puts
$538​M
Net Calls
-⁠$24.9​M
Net Calls Change
+$68.6​M

BSX Hedge Fund Activity: Q4 2023 in Review

1,150 of the 6,876 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2023, worth a combined $77.3B — up 9.5% from $70.6B a quarter earlier.

Buyers outnumbered sellers: 101 funds opened new BSX positions and 69 closed out — a net gain of 32 holders — while 443 added to existing stakes and 378 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $658M. The largest seller was Citadel Advisors, cutting an estimated $650M.

  • 1,150 institutional investors held Boston Scientific (BSX) as of Q4 2023, up from 1,056 in Q3 2023.
  • Funds reported $77.3B of Boston Scientific stock for Q4 2023, up 9.5% quarter-over-quarter.
  • 101 funds opened new Boston Scientific positions in Q4 2023 and 69 closed out, a net change of +32 holders.
  • The largest Boston Scientific buyer in Q4 2023 was Fidelity Investments, an estimated $658M added.
  • The largest Boston Scientific seller in Q4 2023 was Citadel Advisors, an estimated $650M sold.

Based on aggregated 13F filings for Q4 2023.